SEC Tracker
Get the app

Keros Therapeutics KROS

Keros Therapeutics: makes a Regulation FD disclosure

Form
8-K
Filed
Importance
Routine
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Keros Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float $300M to $2B, nearest public float first, as each company reports it on its annual report cover.

  1. CytoDyn CYDY public float $418M, Nov 30, 2025
  2. KalVista Pharmaceuticals KALV public float $499M, Jun 30, 2025
  3. Cryoport CYRX public float $400M, Jun 30, 2025
  4. Capricor Therapeutics CAPR public float $399M, Jun 30, 2025
  5. Elite Pharmaceuticals ELTP public float $534M, Sep 30, 2025